Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Coherent Fluctuation Nephelometry Used to Diagnose Bacteriuria

By LabMedica International staff writers
Posted on 20 Aug 2018
Urinary tract infections (UTI) belong to the most common infectious diseases, making 20% to 49% of all nosocomial infections. More...
For correct UTI diagnosis, the knowledge about the presence of microorganisms in urine is needed and such diagnosis is traditionally carried out by culture methods using solid nutrient media.

Specialized analyzers are used to automate the diagnosis of bacteriuria in laboratory practice. They are based on analysis of microorganisms concentration in urine samples or recording the growth of urine microflora. Coherent fluctuation nephelometry (CFN) has high sensitivity and allows analyzing both parameters simultaneously.

Scientists at the M.F. Vladimirsky Moscow Regional Clinical and Research Institute (Moscow, Russian Federation) collected 117 urine samples for routine microbiological testing in hospital and outpatient departments. Every urine sample was divided into three parts. One part was used for culturing on Uriselect chromogenic agar. The second part was tested using the CFN-analyzer; and the third part was analyzed using UF-1000i.

Urine samples were centrifuged for 60 seconds at 3,000 rpm (1,700 g) to sediment large impurities (such as cells, salts, mucus). During such centrifugation, microorganisms do not sediment onto the bottom of the test tube and stay in the volume of the liquid. Then 0.5 mL of the supernatant was mixed with 0.5 ml sugar broth, placed into disposable 1 mL semi-micro cuvettes, and closed with disposable stoppers. The team placed the cuvettes into CFN-P-12 analyzer and incubated for eight hours.

The scientists reported that in 21 urine samples (18%), significant bacteriuria was determined (equal to or greater than 104 CFU/mL). The best diagnostic indicators were obtained while testing urine samples using the CFN-analyzer. The most efficient bacteriuria diagnosis was achieved by simultaneous analyses of microorganisms concentration in urine and growth of urine microflora. The CFN-analyzer allows the preliminary selection of negative urine samples, which do not require further analysis by conventional microbiological methods, thereby decreasing the number of cultures by 80.3%. The authors concluded that their study suggests that the CFN-analyzer is the effective tool for bacteriuria screening in children. The study was published online on July 18, 2018, in the journal Practical Laboratory Medicine.

Related Links:
M.F. Vladimirsky Moscow Regional Clinical and Research Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.